Is it time to consider a role for MRI before prostate biopsy? (Q37427381)

20 August 2017

1 reference

title

Is it time to consider a role for MRI before prostate biopsy? (English)

1 reference

magnetic resonance imaging

20 August 2017

0 references

0 references

7

Mark Emberton

1 reference

20 August 2017

Hashim U Ahmed

1

1 reference

20 August 2017

Alex Kirkham

2

1 reference

20 August 2017

Manit Arya

3

1 reference

20 August 2017

Rowland Illing

4

1 reference

20 August 2017

Alex Freeman

5

1 reference

20 August 2017

Clare Allen

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

Nature Reviews Clinical Oncology

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

4

1 reference

20 August 2017

197-206

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2009.18

20 August 2017

0 references

cites work

Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images.

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Will focal therapy become a standard of care for men with localized prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

31 March 2020

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

How good is MRI at detecting and characterising cancer within the prostate?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

MAGNETIC RESONANCE IMAGING OF CLINICALLY LOCALIZED PROSTATIC CANCER

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Diffusion-weighted imaging of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

20-year outcomes following conservative management of clinically localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Evidence for a biopsy derived grade artifact among larger prostate glands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Magnetic resonance imaging of prostatic cancer: does detection vary between high and low gleason score tumors?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Psychological benefits of prostate cancer screening: the role of reassurance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

The value of endorectal MRI in the early diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Why do men refuse or attend population-based screening for prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Comparative accuracy: assessing new tests against existing diagnostic pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Imaging prostate cancer: a multidisciplinary perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

MR imaging in local staging of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Optimization of prostate carcinoma staging: comparison of imaging and clinical methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Combined MRI and MR spectroscopy of the prostate before radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or=10, and clinically localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Definition of the prostate in CT and MRI: a multi-observer study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

MR-guided interventions for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Measurement of prostate rotation during insertion of needles for brachytherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Complications of transrectal versus transperineal prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Nonpalpable prostate cancer: detection with MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Active surveillance for prostate cancer: for whom?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Early outcomes of active surveillance for localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Is tumor volume an independent prognostic factor in clinically localized prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

The changing face of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Radical prostatectomy versus watchful waiting in early prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.18

Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology

31 March 2020

1 reference

12 December 2020

High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases

1 reference

12 December 2020

Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer

1 reference

12 December 2020

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

12 December 2020

Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging

1 reference

12 December 2020

Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging

1 reference

12 December 2020

Registering histological and MR images of prostate for image-based cancer detection

1 reference

12 December 2020

Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?

1 reference

12 December 2020

Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature

1 reference

12 December 2020

10.1038/NRCLINONC.2009.18

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference